title: Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
abstract: OBJECTIVE
  To compare the clinical results and reproductive outcome in obese women with polycystic ovary syndrome (PCOS) following dietary intervention or treatment with metformin.
  
  
  METHODS
  Forty-six patients with PCOS were studied prospectively in Prince Rashed Hospital, Irbid, Jordan, between January 2003 and April 2005. The women were randomly divided into 2 groups: Group 1 (n=24) was prescribed with 1200-1400 kcal/day diet (25% proteins, 25% fat, and 50% carbohydrates plus 25-30 gm of fiber per week). Group 2 (n=22) was assigned to take 850 mg of metformin twice in a continuous manner. Both treatments continued for 6 months. Clinical and biochemical data, before and after both treatments along with the reproductive outcome were compared between the 2 groups.
  
  
  RESULTS
  There were no significant differences between the 2 groups in terms of age, body mass index (BMI) and duration of infertility. Both groups had a significant improvement after treatment in the menstrual cyclicity (66.7% and 68.2% versus 12.5% and 18.2%) and significant reduction in BMI (mean of 27.4 and 27.8 versus 32.2 and 31.9), luteinizing hormone levels (7.9+/-1.7 and 6.9+/-1.8 versus 11.8+/-2.2 and 11.5+/-1.8), and androgen (testosterone, androstenedione, dehydroepiandrosterone sulfate) concentration. The clinical, biochemical, and reproductive outcome including menstrual cycle pattern, ovulation, and pregnancy rates were similar in both groups after treatment.
  
  
  CONCLUSIONS
  Amelioration of hyperinsulinemia and hyperandrogenemia with dietary intervention or metformin treatment improves significantly the clinical features and reproductive function in overweight PCOS women.
authors.affiliation: Department of Obstetrics & Gynecology, Royal Medical Services, Irbid, Aidoun, PO Box 97, Jordan. hqublan@yahoo.com
authors.forename: Hussein S
authors.initials: HS
authors.lastname: Qublan
authors.forename: Eleni K
authors.initials: EK
authors.lastname: Yannakoula
authors.forename: Mohamad A
authors.initials: MA
authors.lastname: Al-Qudah
authors.forename: Fahmi I
authors.initials: FI
authors.lastname: El-Uri
mesh_terms: D000328:Adult; D016009:Chi-Square Distribution; D004038:Diet, Reducing; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008598:Menstruation / Q000502:physiology; D008687:Metformin / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications* / Q000178:diet therapy* / Q000188:drug therapy* / Q000503:physiopathology; D010060:Ovulation / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000503:physiopathology; D011247:Pregnancy; D018873:Pregnancy Rate; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin